Bharat Parenterals Limited Q3 FY26 results deck summary

Results deck of 30 Jan 2026, summarised by AI from the filing.

BPL Q3 FY26 standalone revenue ₹41.4 cr (down 39% YoY) on institutional timing; expects Q4 FY26 recovery to ₹50–55 cr.

Key takeaways

1. Q3 FY26 revenue Standalone revenue from operations ₹41.4 cr (Q3 FY25: ₹67.3 cr, -39% YoY; Q2 FY26: ₹41.7 cr, -1% QoQ).
2. Q4 FY26 guidance Expects sequential recovery in Q4FY26, with revenue projected to reach approximately ₹50–55 crore.
3. EBITDA margin Standalone EBITDA margin expanded sequentially by 280 basis points to 8% from 5.6% in Q2 FY26.
4. Order book FY27 expected to benefit from spill-over execution of ₹303 crore order book, particularly in first half.

Original filing on BSE

Bharat Parenterals Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (5 Aug 2026)
• Q4 FY26: Earnings call (19 May 2026), Results deck (18 May 2026)
• Q3 FY26: Results deck (30 Jan 2026)
• Q2 FY26: Earnings call (12 Nov 2025), Results deck (12 Nov 2025)
• Q1 FY26: Results deck (28 Jul 2025)
• Q4 FY25: Earnings call (14 May 2025)